KYMR

Kymera Therapeutics (KYMR)

‌

About Kymera Therapeutics (KYMR)

Kymera Therapeutics, Inc. is a biopharmaceutical company, which engages in the discovery and development of small molecule therapeutics that degrade disease-causing proteins. The company was founded by Bruce Lee Booth and Nello Mainolfi in September 2015 and is headquartered in Watertown, MA.

Details

Daily high

$35.48

Daily low

$33.11

Price at open

$35.44

52 Week High

$53.27

52 Week Low

$29.07

Market cap

2.3B

Dividend yield

0.00%

Volume

694,945

Avg. volume

732,436

P/E ratio

-11.83

Kymera Therapeutics News